{
  "name": "Four routes for generating monoclonal antibodies compared",
  "description": "Compares hybridoma, phage display, transgenic mouse and single B cell routes on animal requirement, expression host and glycosylation, library size and stated limits. Compiled by the CASRAI editors from the statements in one peer-reviewed 2021 review of antibody discovery technology; blank values are marked as not stated rather than estimated.",
  "page": "https://casrai.org/guides/how-are-monoclonal-antibodies-produced",
  "publisher": "CASRAI",
  "license": "https://creativecommons.org/licenses/by/4.0/",
  "dateModified": "2026-11-14T20:47:19Z",
  "temporalCoverage": null,
  "spatialCoverage": null,
  "columns": [
    {
      "name": "Route",
      "unit": "",
      "description": ""
    },
    {
      "name": "Animal host needed to generate antibodies",
      "unit": "",
      "description": ""
    },
    {
      "name": "Expression host and glycosylation",
      "unit": "",
      "description": ""
    },
    {
      "name": "Library size",
      "unit": "",
      "description": ""
    },
    {
      "name": "Limits stated in the review",
      "unit": "",
      "description": ""
    }
  ],
  "rows": [
    {
      "Route": "Hybridoma",
      "Animal host needed to generate antibodies": "Yes, animals are immunized with the antigen",
      "Expression host and glycosylation": "Hybridoma (eukaryotic) cells; hybridoma-derived antibodies for therapy are converted by chimerization or humanization",
      "Library size": "Not applicable (clones from fused B cells)",
      "Limits stated in the review": "Low efficiency of cell fusion and hybridoma isolation; hybridoma lines may be genetically unstable"
    },
    {
      "Route": "Phage display",
      "Animal host needed to generate antibodies": "No animal host required",
      "Expression host and glycosylation": "Selected antibodies made in E. coli, so not glycosylated",
      "Library size": "About 10^10 to 10^11 variants (ribosome display about 10^14)",
      "Limits stated in the review": "Library size limited by bacterial transformation efficiency; no glycosylation in E. coli"
    },
    {
      "Route": "Transgenic mice with human Ig loci",
      "Animal host needed to generate antibodies": "Yes, transgenic mice are immunized",
      "Expression host and glycosylation": "Murine hybridomas secreting human antibodies",
      "Library size": "Not applicable",
      "Limits stated in the review": "Shares hybridoma limits; first approved example was panitumumab (2006)"
    },
    {
      "Route": "Single B cell cloning",
      "Animal host needed to generate antibodies": "No; B cells from vaccinated or naturally immunized humans, or from animal samples collected without euthanasia",
      "Expression host and glycosylation": "Antibody genes cloned into expression cassettes for cell-based or cell-free expression",
      "Library size": "Not stated",
      "Limits stated in the review": "Single-cell sorting devices are expensive; cell-free expression can give incorrect folding of antibody domains"
    }
  ],
  "sources": [
    {
      "title": "Moraes JZ et al. Hybridoma technology: is it still useful? Curr Res Immunol 2021",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC9040095",
      "accessed": "2026-11-14"
    }
  ]
}